Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 12861-12870 of 13618

Page
per page
  1. VX-11e
    A3931 VX-11e
     5 Citation
    Target: ERK
    Summary: ERK inhibitor
      ≥25 mg/mL
  2. 6-Chloro-L-tryptophan
    BA9297 6-Chloro-L-tryptophan
    Summary: 6-Chloro-L-tryptophan is a tryptophan derivative.
  3. DiscoveryProbe™ FDA-approved Drug Library Mini
    L1021M DiscoveryProbe™ FDA-approved Drug Library Mini
    Summary: A unique collection of 1592 approved bioactive compounds.
  4. α-Tocopherol-d6
    SL1002 α-Tocopherol-d6
    Summary: A stable isotope deuterated compound of α-Tocopherol
  5. OSS_128167
    B8369 OSS_128167
    Summary: A selective SIRT6 inhibitor with anti-HBV, anticancer, and anti-inflammatory activities.
      insoluble in EtOH; insoluble in H2O; ≥101.8 mg/mL
  6. Batoprotafib
    C9107 Batoprotafib
    Summary: A research-use SHP2 allosteric inhibitor for studies of the RAS–MAPK signaling pathway.
      ≥50.9 mg/mL
  7. PMPA (NAALADase inhibitor)
    A4414 PMPA (NAALADase inhibitor)
    Summary: Glutamate carboxypeptidase 2 inhibitor
      Soluble to 100 mM in sterile water
  8. Sivelestat sodium salt
    A4430 Sivelestat sodium salt
    Target: Elastases
    Summary: Leukocyte elastase inhibitor
      ≥54.8 mg/mL
  9. BC 11 hydrobromide
    A4444 BC 11 hydrobromide
    Summary: Selective urokinase inhibitor
      <29.1 mg/mL
  10. R18
    A4446 R18
    Summary: 14.3.3 proteins Antagonist
      Soluble to 1 mg/mL

Items 12861-12870 of 13618

Page
per page